Daily Newsletter

31 August 2023

Share with colleague
Subscribe

Daily Newsletter

31 August 2023

Share with colleague
Subscribe

Spotlight

Portugal’s Luisadas Saude Health deploys PrecisePK precision dosing tech

The collaboration equips clinicians with evidence-based tools for clinical decision support.

Latest news

Macquarie offers financing for new Southampton healthcare facility

The new facility will include a sterile services facility, aseptic pharmacy, office space, and parking.

31 August 2023

Over 400 Irish hospital consultants accept new public-only contracts

The contracts offer salaries up to €252,000 and bar consultants from conducting private work at public hospitals.

31 August 2023

Gold Coast University Hospital facility’s first look at prototypes unveiled

The facility will provide a home-like environment and is slated for opening in 2025.

31 August 2023

Rady Children’s Hospital-San Diego breaks ground on expansion

The facility will feature paediatric, neonatal and cardiac ICUs, as well as a new emergency department and modern operating rooms.

31 August 2023

Cape Fear and Harnett to build cancer centre in North Carolina

The project will involve building a three-storey, 66,000ft² facility at the hospital.

31 August 2023

Peab to build forensic psychiatric hospital in Vaasa, Finland

The project involves building a two-storey, 5,500m² building at Vaasa Hospital to replace an outdated hospital building.

31 August 2023

Healthcare companies using Google Cloud generative AI tools

Huma said it expects the technology to automate its clinical summary reports and improve its data triaging processes.

31 August 2023

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.